<DOC>
	<DOC>NCT01101945</DOC>
	<brief_summary>The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.</brief_summary>
	<brief_title>Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Completed Visit 7/Day 98 of the core protocol PHX1149PROT202 Current treatment of Type 2 diabetes mellitus in accordance with product labeling with metformin, or thiazolidinedione (TZD), or metformin + TZD Inadequately controlled Type 2 diabetes mellitus with need for therapy with insulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>diabetes</keyword>
	<keyword>DPP4 inhibitor</keyword>
	<keyword>dutogliptin</keyword>
	<keyword>PHX1149</keyword>
</DOC>